Dilemma of clinically node-negative head and neck melanoma: Outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy - A systematic review

Head and Neck

Volumn 30, Issue 3, 2008, Pages 380-389

  Tanis, Pieter J ^a   Nieweg, Omgo E ^b   Van Den Brekel, Michiel W M ^a,b   Balm, Alfons J M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Head and neck; Lymph node dissection; Melanoma; Sentinel node; Survival

Indexed keywords

ANATOMY; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; HEAD AND NECK MELANOMA; HUMAN; LYMPH NODE DISSECTION; MELANOMA; NECK DISSECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL NODE BIOPSY; SYSTEMATIC REVIEW; TUMOR BIOPSY;

DECISION MAKING; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MELANOMA; NECK DISSECTION; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 41649102119     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20749     Document Type: Article

References (87)

1. Gibbs P, Robinson WA, Pearlman N, Raben D, Walsh P, Gonzalez R. Management of primary cutaneous melanoma of the head and neck: the University of Colorado experience and a review of the literature. J Surg Oncol 2001;77:179-185.
2. Kane WJ, Yugueros P, Clay RP, Woods JE. Treatment outcome for 424 primary cases of clinical I cutaneous malignant melanoma of the head and neck. Head Neck 1997;19:457-465.
3. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131-149.
4. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-314.
5. Leong SP, Accortt NA, Essner R, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 2006;132:370-373.
6. Stitzenberg KB, Thomas NE, Beskow LM, Ollila DW. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100-107.
7. Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982; 196:677-684.
8. Day TA, Hornig JD, Sharma AK, Brescia F, Gillespie MB, Lathers D. Melanoma of the head and neck. Curr Treat Options Oncol 2005;6:19-30.
9. O'Brien CJ, Gianoutsos MP, Morgan MJ. Neck dissection for cutaneous malignant melanoma. World J Surg 1992; 16:222-226.
10. Lentsch EJ, Myers JN. Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope 2001;111:1209-1222.
11. Blum A, Schlagenhauif B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer 2000;88:2534-2539.
12. Brountzos EN, Panagiotou IE, Bafaloukos DI, Kelekis DA. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma. Oncol Rep 2003;10:505-510.
13. Machet L, Nemeth-Normand F, Giraudeau B, et al. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients. Br J Dermatol 2005;152:66-70.
14. Dessureault S, Soong SJ, Ross MI, et al. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 2001; 8:766-770.
15. Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther 2003;3:673-683.
16. Pathak I, O'Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck 2001;23:785-790.
17. de Wilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004;239:544-552.
18. Eberbach MA, Wahl RL, Argenta LC, Froelich J, Niederhuber JE. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. Surgery 1987;102:433-442.
19. Wells KE, Cruse CW, Daniels S, Berman C, Norman J, Reintgen DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 1994; 93:757-761.
20. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87-97.
21. Hansson J, Ringborg U, Lagerlof B, et al. Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group. Melanoma Res 1994;4:407-411.
22. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 1984;200:769-775.
23. Olson RM, Woods JE, Soule EH. Regional lymph node management and outcome in 100 patients with head and neck melanoma. Am J Surg 1981;142:470-473.
24. Conley J, Hamaker RC. Melanoma of the head and neck. Laryngoscope 1977;87:460-464.
25. Ames FC, Sugarbaker EV, Ballantyne AJ. Analysis of survival and disease control in stage I melanoma of the head and neck. Am J Surg 1976;132:484-491.
26. Loree TR, Spiro RH. Cutaneous melanoma of the head and neck. Am J Surg 1989;158:388-391.
27. Wilmes E, Bujia J. Recommendations for therapy of head and neck cutaneous melanoma. Am J Otolaryngol 1993;14:267-270.
28. Peralta EA, Yarington CT, Glenn MG. Malignant melanoma of the head and neck: effect of treatment on survival. Laryngoscope 1998;108:220-223.
29. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998; 351:793-796.
30. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 1978;41:948-956.
31. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
32. Vreeburg GC, Schouwenburg PF, Hilgers FJ, de Kraker NW, Hart AA. Cutaneous melanoma of the head and neck. Eur J Surg Oncol 1988;14:165-170.
33. Fisher SR. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Laryngoscope 2002;112:99-110.
34. Bonnen MD, Ballo MT, Myers JN, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004; 100:383-389.
35. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992;127:392-399.
36. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
37. Tanis PJ, Nieweg OE, Valdes Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res 2001;3:109-112.
38. Pu LL, Wells KE, Cruse CW, Shons AR, Reintgen DS. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck. Plast Reconstr Surg 2003;112:43-49.
39. Nieweg OE, Jansen L, Kroon BB. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol 1998;24:520-524.
40. Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg 1997;174:536-539.
41. Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg 1997;100:591-594.
42. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10:21-26.
43. Eicher SA, Clayman GL, Myers JN, Gillenwater AM. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2002;128:241-246.
44. Mariani G, Erba P, Manca G, et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J Surg Oncol 2004;85:141-151.
45. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170:461-466.
46. Rasgon BM. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study. Laryngoscope 2001; 111:1366-1372.
47. Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003;44:1413-1420.
48. Kapteijn BA, Nieweg OE, Valdes Olmos RA, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996;37: 972-975.
49. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-311.
50. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck 2000;22:27-33.
51. Maccauro M, Villano C, Aliberti G, et al. Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas. Q J Nucl Med Mol Imaging 2005;49:245-251.
52. Ollila DW, Foshag LJ, Essner R, Stern SL, Morton DL. Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol 1999;6:150-154.
53. Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 2002;24:282-289.
54. Hoft S, Muhle C, Brenner W, Sprenger E, Maune S. Fine-needle aspiration cytology of the sentinel lymph node in head and neck cancer. J Nucl Med 2002;43: 1585-1590.
55. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469-474.
56. Lin D, Franc BL, Kashani-Sabet M, Singer MI. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck 2006;28:249-255.
57. Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-688.
58. Gussack GS, Reintgen D, Cox E, Fisher SR, Cole TB, Seigler HF. Cutaneous melanoma of the head and neck. A review of 399 cases. Arch Otolaryngol 1983;109:803-808.
59. Carlson GW, Murray DR, Greenlee R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg 2000;126:433-437.
60. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538-549.
61. Jacobs IA, Chevinsky AH, Swayne LC, Magidson JG, Britto EJ, Smith TJ. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: reliability of the procedure and analysis of failures after long-term follow-up. J Surg Oncol 2001;77: 157-164.
62. Kokoska MS, Olson G, Kelemen PR, et al. The use of lymphoscintigraphy and PET in the management of head and neck melanoma. Otolaryngol Head Neck Surg 2001;125:213-220.
63. Alex JC, Krag DN, Harlow SP, et al. Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:135-140.
64. Maffioli L, Belli F, Gallino G, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck. Tumori 2000;86:341-342.
65. Loree TR, Tomljanovich PI, Cheney RT, Hicks WL Jr, Rigual NR. Intraparotid sentinel lymph node biopsy for head and neck melanoma. Laryngoscope 2006;116:1461-1464.
66. Leong SP, Achtem TA, Habib FA, et al. Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol 1999;135:1472-1476.
67. Doting EH, de VM, Plukker JT, et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol 2006;93:564-570.
68. Medina-Franco H, Beenken SW, Heslin MJ, Urist MM. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol 2001;8:716-719.
69. Fincher TR, O'Brien JC, McCarty TM, et al. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck. Arch Otolaryngol Head Neck Surg 2004;130:844-848.
70. Patel SG, Coit DG, Shaha AR, et al. Sentinel lymph node biopsy for cutaneous head and neck melanomas. Arch Otolaryngol Head Neck Surg 2002;128:285-291.
71. Wagner JD, Park HM, Coleman JJ III, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 2000;126:313-321.
72. Stadelmann WK, Cobbins L, Lentsch EJ. Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients. Ann Plast Surg 2004;52:546-549.
73. Schmalbach CE, Nussenbaum B, Rees RS, Schwartz J, Johnson TM, Bradford CR. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2003; 129:61-65.
74. Carlson GW, Murray DR, Lyles RH, Hestley A, Cohen C. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma. Plast Reconstr Surg 2005;115:721-728.
75. Giese T, Engstner M, Mansmann U, Hartschuh W, Arden B. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. J Invest Dermatol 2005;124:633-637.
76. Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005;29:305-317.
77. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004;11:162S-168S.
78. Morton DL, Thompson JF, Cochran AJ, et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. Presented at the ASCO Annual Meeting, May 13-17 2005,Orlando, Florida.
79. Blum A, Schmid-Wendtner MH, Mauss-Kiefer V, Eberle JY, Kuchelmeister C, Dill-Muller D. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study. Dermatology 2006;212:47-52.
80. Thompson JF, Shaw HM. Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first Multicenter Selective Lymphadenectomy Trial. ANZ J Surg 2006;76:100-103.
81. Doubrovsky A, de Wilt JH, Scolyer RA, McCarthy WH, Thompson JF. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2004; 11:829-836.
82. McMasters KM. What good is sentinel lymph node biopsy for melanoma if it does not improve survival? Ann Surg Oncol 2004;11:810-812.
83. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-1317.
84. Kretschmer L, Hilgers R, Mohrle M, et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 2004;40:212-218.
85. Rutkowski P, Nowecki ZI, Nasierowska-Guttmejer A, Ruka W. Lymph node status and survival in cutaneous malignant melanoma - sentinel lymph node biopsy impact. Eur J Surg Oncol 2003;29:611-618.
86. Means JH. Thyroid and its diseases. Philadelphia: JB Lippincott; 1948.
87. Thomas JM. Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg 2006;93:129-130.